Advanced Health Limited Stocks

ZAC 0Last Updated 23.03.2026

Issuer Rating

3/7
Performance

Average

Risk

High

Recommendation

Sell

Market Cap

ZAC 29.13M

Buy
Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
ZAC 0
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very low or no dividends

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Advanced Health Limited, together with its subsidiaries, provides short-procedure surgical services and diagnostic procedures through a network of day hospitals. It offers plastic surgery, such as blepharoplasty, breast augmentation, facelift, labiaplasty, liposuction, mastopexy, rhinoplasty, and otoplasty; dermatological services, including cauterization nevus, lipoma, mole and wart removal, and scar excision/ revision surgery; urology services, such as circumcision, cystoscopy and ureteral dilation, inguinal hernia repair, prostate biopsy, renal calcultus removal and stent insertion, scope and pyelogram, vasectomy, and vasostomy; and ophthalmology services, including cataract, corneal, laser surgery, intraocular injection, posterior and anterior vitrectomy, tear ducts repair, and pterygium and removal; and gynecological services, such as cauterization, cervical cerclage and lletz, dilatation and curetation, drainage of bartholin cyst, endometrial ablation, hysteroscopy, insertion intrauterine device, labiaplasty, laparoscopic sterilization, and cyst removal. The company also provides orthopedic services, including arthroscopy, bunionectomy, carpal tunnel release, ganglionectomy, insertion/removal of k wires, toenail resection, achille tendon release, pins and plates removal, peripheral nerve neuroplasty, trigger finger release, fracture reduction, and pain management; ENT services, such as adenoidectomy, antrostomy, bone anchor external hearing device, cochlear implant, diagnostic proof puncture, endoscopy, electro cauterization, myringotomy, nose fracture reduction, rhinoplasty, septoplasty, tonsillectomy, turbinectomy, and tympanoplasty; and maxillofacial and dental services, including apisectomy, extraction, frenectomie, gingival graft, orthodontic attachment, sinus augmentation, and teeth removal. It operates 4-day hospitals in Australia and 11-day hospitals in South Africa. The company was incorporated in 2013 and is based in Pretoria, South Africa.

Company Valuation

Slightly undervalued
5/7

From both historical and forecast perspectives, the stock is moderately underpriced compared to similar stocks. Specifically, the stock is 'cheap' on P/E, neutral on EV/E

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis
X-channel

Buy

Sell

0 more stocks